This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
CK2α-mediated phosphorylation of GRP94 facilitates the metastatic cascade in triple-negative breast cancer
Cell Death Discovery Open Access 22 April 2024
-
Phenotypic Transitions the Processes Involved in Regulation of Growth and Proangiogenic Properties of Stem Cells, Cancer Stem Cells and Circulating Tumor Cells
Stem Cell Reviews and Reports Open Access 19 February 2024
-
MiRNA-related metastasis in oral cancer: moving and shaking
Cancer Cell International Open Access 27 August 2023
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70.
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.
Fouad YA, Aanei C. Revisiting the hallmarks of cancer. Am J Cancer Res. 2017;7:1016.
Hanahan D. Rethinking the war on cancer. Lancet. 2014;383:558–63.
Lazebnik Y. What are the hallmarks of cancer? Nat Rev Cancer. 2010;10:232.
Chegini N. Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder. Semin Reprod Med. 2010;28:180–203.
Marino-Enriquez A, Fletcher CD. Shouldn’t we care about the biology of benign tumours? Nat Rev Cancer. 2014;14:701.
Monleón D, Morales JM, Gonzalez-Segura A, Gonzalez-Darder JM, Gil-Benso R, Cerdá-Nicolás M, et al. Metabolic aggressiveness in benign meningiomas with chromosomal instabilities. Cancer Res. 2010;70:8426–34.
Reiman JM, Kmieciak M, Manjili MH, Knutson KL. Tumor immunoediting and immunosculpting pathways to cancer progression. Semin Cancer Biol. 2007;17:275–87.
Yigit R, Massuger LF, Zusterzeel PL, Pots J, Figdor CG, Torensma R. Cytokine profiles in cyst fluids from ovarian tumors reflect immunosuppressive state of the tumor. Int J Gynecologic Cancer. 2011;21:1241–7.
Meirson T, Gil-Henn H. Targeting invadopodia for blocking breast cancer metastasis. Drug Resistance Updates. 2018;39:1–17.
Gandalovičová A, Rosel D, Fernandes M, Veselý P, Heneberg P, Čermák V, et al. Migrastatics—anti-metastatic and anti-invasion drugs: promises and challenges. Trends Cancer. 2017;3:391–406.
Hayes KE, Walk EL, Ammer AG, Kelley LC, Martin KH, Weed SA. Ableson kinases negatively regulate invadopodia function and invasion in head and neck squamous cell carcinoma by inhibiting an HB-EGF autocrine loop. Oncogene. 2013;32:4766.
Linde N, Casanova-Acebes M, Sosa MS, Mortha A, Rahman A, Farias E, et al. Macrophages orchestrate breast cancer early dissemination and metastasis. Nat Commun. 2018;9:21.
Meirson T, Genna A, Lukic N, Makhnii T, Alter J, Sharma VP, et al. Targeting invadopodia-mediated breast cancer metastasis by using ABL kinase inhibitors. Oncotarget. 2018;9:22158.
Paz H, Pathak N, Yang J. Invading one step at a time: the role of invadopodia in tumor metastasis. Oncogene. 2014;33:4193.
Revach O-Y, Sandler O, Samuels Y, Geiger B. Cross-talk between receptor tyrosine kinases AXL and ERBB3 regulates invadopodia formation in melanoma cells. Cancer Res. 2019;79:2634–48.
Nemlich Y, Baruch EN, Besser MJ, Shoshan E, Bar-Eli M, Anafi L. ADAR1-mediated regulation of melanoma invasion. Nat Commun. 2018;9:2154.
Sleeman J, Steeg PS. Cancer metastasis as a therapeutic target. Eur J Cancer. 2010;46:1177–80.
Karagiannis GS, Condeelis JS, Oktay MH. Chemotherapy-induced metastasis: mechanisms and translational opportunities. Clin Exp Metastasis. 2018;35:269–84.
Acknowledgements
This work was supported by the Israel Cancer Association and Estee Lauder Companies (grant number 20180089), the Israel Science Foundation (grant number 1462/17), and the Israel Cancer Research Fund (grant number 17-902-AG) (to HG-H), and by Leir Foundation and the Ginzburg Foundation (to AOS). TM is supported by the Foulkes Foundation fellowship for MD/PhD students.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Meirson, T., Gil-Henn, H. & Samson, A.O. Invasion and metastasis: the elusive hallmark of cancer. Oncogene 39, 2024–2026 (2020). https://doi.org/10.1038/s41388-019-1110-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41388-019-1110-1
This article is cited by
-
CK2α-mediated phosphorylation of GRP94 facilitates the metastatic cascade in triple-negative breast cancer
Cell Death Discovery (2024)
-
Exosomes released by oxidative stress-induced mesenchymal stem cells promote murine mammary tumor progression through activating the STAT3 signaling pathway
Molecular and Cellular Biochemistry (2024)
-
Phenotypic Transitions the Processes Involved in Regulation of Growth and Proangiogenic Properties of Stem Cells, Cancer Stem Cells and Circulating Tumor Cells
Stem Cell Reviews and Reports (2024)
-
MiRNA-related metastasis in oral cancer: moving and shaking
Cancer Cell International (2023)
-
The kinesin Eg5 inhibitor K858 exerts antiproliferative and proapoptotic effects and attenuates the invasive potential of head and neck squamous carcinoma cells
Investigational New Drugs (2022)